Hospital or health organisation · founded 1904
Fox Chase Cancer Center
Philadelphia, United States · foxchase.org
Part of Temple University Health System
- Citations, last 5 years
- 62.9k
- Works, last 5 years
- 4 126
- h-index
- 738
- Scientists listed
- 0
- Grants since 2016
- 606
Grants received
2023–2027 · research · R01
Neighborhood, social connectedness, and allostatic load in US Chinese immigrants
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Role of ZBP1 in pathogenesis of Salmonella biofilms
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Fibroblasts Support the Growth of Brain Metastasis by Rendering Cancer Cells Resistant to Chemotherapy and Inducing Immunosuppression in Tumor Microenvironment
Zeng-Jie Yang · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Neighborhood, social connectedness, and allostatic load in US Chinese immigrants
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer
Lorenzo Galluzzi · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2025 · research · R21
Interaction of cannabidiol (CBD) with targeted inhibitors of essential cancer signaling pathways
Erica A. Golemis · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Divergent Functions of ERK Substrate Binding Domains in Pathogenesis of Myeloproliferative Neoplasms
Tomasz Skorski · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · training · T32
Training Grant in Precision Cancer Control
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2025 · research · R03
Role of the Parkinson's susceptibility gene LRRK2 in NFAT-mediated malignant mesothelioma tumorigenesis
Joseph R. Testa · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2024 · research · R56
Harnessing ZBP1-triggered cell death to enhance influenza vaccine responsiveness
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2027 · research · R01
Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Fibroblasts Support the Growth of Brain Metastasis by Rendering Cancer Cells Resistant to Chemotherapy and Inducing Immunosuppression in Tumor Microenvironment
Zeng-Jie Yang · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Elucidating the critical role of Wee1 in GIST
Lori Rink · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Elucidating the critical role of Wee1 in GIST
Lori Rink · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2026 · contract · N01
PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate BiomarkersTask Order Title: Sulforaphane for the Prevention of Malignant Mesothelioma
Joseph Testa · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2026 · research · R21
Interaction of cannabidiol (CBD) with targeted inhibitors of essential cancer signaling pathways
Erica A. Golemis · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2025 · award
Epigenetic determinants of melanoma progression and immunotherapy response
Alfonso Bellacosa · Fox Chase Cancer Center · funded by Melanoma Research Alliance
2023–2025 · award
Thyroid hormone regulates the terminal differentiation of tumor cells in SHH group medulloblastoma
Zeng-Jie Yang · Fox Chase Cancer Center · funded by American Cancer Society
2023–2025 · award
Identifying genetic sex biasing factors in melanoma progression
Nora Engel · Fox Chase Cancer Center · funded by Melanoma Research Alliance
2023–2028 · research · R01
Divergent Functions of ERK Substrate Binding Domains in Pathogenesis of Myeloproliferative Neoplasms
Tomasz Skorski · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2025 · cooperative agreement · UG3
Asian American Community Cohort and Equity Study (ACCESS)
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2025 · career development · K99
Elucidating the epigenetic regulation of extracellular matrix and virus-induced fibroblast activation
Jaye C Gardiner · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · research · R35
Telomerase RNP Prisonbreaks from Phase-Separated Nuclear Body
Lu Chen · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2025 · career development · K99
Elucidating the epigenetic regulation of extracellular matrix and virus-induced fibroblast activation
Jaye C Gardiner · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Examining the Relationship between Residential History at Midlife and Prostate Cancer Outcomes
Charnita M. Zeigler-Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2024 · research · R13
Community to Molecular Approaches in Early Screening and Diagnosis to Promote Equitable Outcomes Through the Continuum of Care in Cancer Among Populations of African Ancestry
Samuel Gathere · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Examining the Relationship between Residential History at Midlife and Prostate Cancer Outcomes
Charnita M. Zeigler-Johnson · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2025 · research · R21
A Phase I Proof-of-Concept Study of CBL0137 Combined with Ipilimumab and Nivolumab Therapy in Locally Advanced or Metastatic Melanoma
Igor Astsaturov · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · training · T32
Training Grant in Precision Cancer Control
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2025 · research · R03
Divergent Functions of ERK2 Substrate Binding Domains in Pathogenesis of KRAS-Driven Pancreatic Cancer
Igor Astsaturov · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2026 · award
Synthetic Cellular Targets for Tumor- Directed Drug Delivery
Swayam Prabha · Fox Chase Cancer Center · funded by American Cancer Society
2023–2028 · research · R35
Telomerase RNP Prisonbreaks from Phase-Separated Nuclear Body
Lu Chen · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2026 · research · R03
Role of the Parkinson's susceptibility gene LRRK2 in NFAT-mediated malignant mesothelioma tumorigenesis
Joseph R. Testa · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2026 · contract · N01
Colorectal Cancer (CRC) Prevention by Urolithin A in Rodent CRC models
Margie L. Clapper · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2027 · award
Non-Proteolytic Ubiquitination in Treatment Resistance of Hodgkin Lymphoma
Yibin Yang · Fox Chase Cancer Center · funded by American Cancer Society
2023–2025 · cooperative agreement · UG3
Asian American Community Cohort and Equity Study (ACCESS)
Carolyn Y. Fang · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Role of ZBP1 in pathogenesis of Salmonella biofilms
Siddharth Balachandran · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2028 · research · R35
Telomerase RNP Prisonbreaks from Phase-Separated Nuclear Body
Lu Chen · Fox Chase Cancer Center · funded by National Institutes of Health
2023–2025 · research · R21
A Phase I Proof-of-Concept Study of CBL0137 Combined with Ipilimumab and Nivolumab Therapy in Locally Advanced or Metastatic Melanoma
Igor Astsaturov · Fox Chase Cancer Center · funded by National Institutes of Health